|
General Information
|
|
|
Product
|
Visfatin Peptide
|
|
Description
|
Antigenic Blocking Peptide Nicotinamide phosphoribosyltransferase precursor Antibody N-epitope
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
N-epitope synthetic peptide taken within amino acid region 200-300 on human Visfatin protein.
|
|
Accession #
|
NCBI: NP_005737.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P43490
|
|
Overview
|
Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma.
|
|
Molecular Function
|
Cytokine, Glycosyltransferase, Transferase
|
|
Subcellular Location
|
Nucleus, Cytoplasm, Secreted
|
|
Expression
|
Expressed in large amounts in bone marrow, liver tissue, and muscle. Also present in heart, placenta, lung, and kidney tissues.
|
|
Structure
|
Homodimer
|
|
Alternative Nomenclature
|
1110035O14Rik antibody
AI314458 antibody
AI480535 antibody
DKFZP666B131 antibody
EC 2.4.2.12 antibody
MGC117256 antibody
NAmPRTase antibody
Nampt antibody
Nicotinamide phosphoribosyltransferase antibody
PBEF antibody
PBEF1 antibody
Pre B cell colony enhancing factor antibody
Pre B cell enhancing factor antibody
VF antibody
Visfatin antibody
|
| |
|
Visfatin Antibody
Visfatin Antibody FITC
Visfatin Antibody BIOTIN
Visfatin Positive Control
